Home > Insider Trading > Filing (0001343238-10-000016)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1472595	Accretive Health Inc.	AH	Services-Management Services (8741)	020698101

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
911380	Taylor J Crandall	2775 Sand Hill Road Suite 220 Menlo Park CA 94025	No	No	Yes	No
1247520	Group Vi 31 Llc	201 Main Street Suite 3100 Fort Worth TX 76102	No	No	Yes	No
1492076	Fw Oak Hill Accretive Healthcare Investors, L.p.	201 Main Street Suite 3100 Fort Worth TX 76102	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-05-25	15,947,601	$0.00	15,947,601	No	4	C	Direct
Common Stock	Acquisiton	2010-05-25	1,477,161	$0.00	17,424,762	No	4	C	Direct
Common Stock	Disposition	2010-05-25	829,486	$11.28	16,595,276	No	4	S	Direct
Common Stock	Acquisiton	2010-05-25	502,696	$0.00	17,097,972	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	S	Direct
No	4	J	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-05-25	13,273	$0.00	15,947,601	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2010-05-25	376,827	$0.00	1,477,161	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

The Series A Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1,201.5069 for one basis and had no expiration date.
The Series D Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 3.92 for one basis and had no expiration date.
FW Oak Hill Accretive Healthcare Investors, L.P. (the "Oak Hill Partnership") elected to receive shares of common stock, based on the initial public offering price of $12.00 per share, in satisfaction of the liquidation preference payment payable to the holders of the Issuer's preferred stock upon the closing of its initial public offering.
Group VI 31, LLC ("Group VI 31") is the sole general partner of the Oak Hill Partnership, which is the direct holder of the shares reported herein. J. Taylor Crandall ("Crandall") is the sole member and President of Group VI 31 and a limited parter of the Oak Hill Partnership. Crandall and Group VI 31 disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.